Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-22-027222

Director acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Titterton Lewis H jr · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-29 Exercise or conversion : show line 1 in the form +40,000 $2.58 $103,000 774,070 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-09-29 Exercise or conversion : show line 2 in the form Employee Stock Option −40,000 0 D
Loading xslF345X03/ownership.xml…